12- hLO inhibitors (NCATS/University of California Santa Cruz/Eastern Virginia Med School/Thomas Jefferson Univ)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name12- hLO inhibitors (NCATS/University of California Santa Cruz/Eastern Virginia Med School/Thomas Jefferson Univ)
Drug Alias Name12-lipoxygenase inhibitors (NCATS/University of California Santa Cruz/Eastern Virginia Med School/Thomas Jefferson Univ)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action12-lipoxygenase inhibitors
Targets12-lipoxygenase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Center For Advancing Translational Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California, Santa CruzNational Institutes Of HealthNational Center For Advancing Translational Sciences +[6] 
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A